220 related articles for article (PubMed ID: 22246157)
1. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
[TBL] [Abstract][Full Text] [Related]
2. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
3. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
Porter CC; Carver AE; Albano EA
Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430
[TBL] [Abstract][Full Text] [Related]
4. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease.
Weimer LH; Podwall D
J Neurol Sci; 2006 Mar; 242(1-2):47-54. PubMed ID: 16386273
[TBL] [Abstract][Full Text] [Related]
5. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
Schiavetti A; Frascarelli M; Uccini S; Novelli A
Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
[TBL] [Abstract][Full Text] [Related]
6. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
7. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
8. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
9. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
10. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
[TBL] [Abstract][Full Text] [Related]
11. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).
Igarashi M; Thompson EI; Rivera GK
Med Pediatr Oncol; 1995 Aug; 25(2):113-6. PubMed ID: 7603395
[TBL] [Abstract][Full Text] [Related]
12. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
Uno S; Katayama K; Dobashi N; Hirano A; Ogihara A; Yamazaki H; Usui N; Kobayashi T; Inoue K; Kuraishi Y
Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
[TBL] [Abstract][Full Text] [Related]
13. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
Hartman A; van den Bos C; Stijnen T; Pieters R
Cancer; 2006 Mar; 106(6):1395-401. PubMed ID: 16453332
[TBL] [Abstract][Full Text] [Related]
14. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease.
Dickerhoff R; Lindner W; Scheiber W
Pediatr Hematol Oncol; 1988; 5(1):61-4. PubMed ID: 3152952
[No Abstract] [Full Text] [Related]
15. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
16. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
17. Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.
Nakamura T; Hashiguchi A; Suzuki S; Uozumi K; Tokunaga S; Takashima H
Neurogenetics; 2012 Feb; 13(1):77-82. PubMed ID: 22271166
[TBL] [Abstract][Full Text] [Related]
18. Vindesine-induced neuropathy mimicking Guillain-Barré syndrome.
Liu L; Shi B; Ye L; Jin J; Zhang Y; Hu W; Liu M; Li G
Leuk Res; 2009 Dec; 33(12):e232-3. PubMed ID: 19428104
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibroma-associated left peroneal nerve palsy in a patient with acute lymphoblastic leukemia].
Mizutani A; Sakata K; Nakajima T; Morimoto A; Tsunamoto K; Shimizu Y; Todo S; Morioka Y; Imashuku S
Rinsho Ketsueki; 1989 Jun; 30(6):878-81. PubMed ID: 2552194
[TBL] [Abstract][Full Text] [Related]
20. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
